SCHEMBL30748842

SCHEMBL30748842

CNc1ncnc2c(-c3ccc(N4CCOCC4)cc3OC)csc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.47
PTK2 Q05397 1/20 0.43
INSR P06213 1/20 0.42
ALK Q9UM73 1/20 0.42
FGFR3 P22607 2/20 0.41
MAPT P10636 5/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HTT P42858 3/20 0.40
PKM P14618 2/20 0.40
AR P10275 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CHEK1 O14757 1/20 0.40
TTK P33981 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
FGFR2 P21802 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30748740 0.85 LRRK2 (0.50) LRRK2PTK2INSRALKFGFR3
SCHEMBL30749101 0.82 LRRK2 (0.44) LRRK2PTK2INSRALKMAPT
SCHEMBL30748957 0.78 LRRK2 (0.41) LRRK2PTK2INSRALKFGFR3
SCHEMBL30808288 0.74 MAPK1 (0.39) MAPTALDH1A1KDM4EHTTPKM
SCHEMBL30748864 0.70 LRRK2 (0.51) LRRK2PTK2INSRALKFGFR3
SCHEMBL24590200 0.68 LRRK2 (0.61) LRRK2PTK2INSRALKMAPT
SCHEMBL14137147 0.68 MAPT (0.52) PTK2MAPTALDH1A1KDM4EHTT
SCHEMBL30748749 0.67 HTR2C (0.43) LRRK2PTK2MAPTALDH1A1KDM4E
SCHEMBL30080932 0.66 TTK (0.58) INSRALKMAPTALDH1A1KDM4E
SCHEMBL2917121 0.66 DHFR (0.56) LRRK2INSRALKCHEK1TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565588-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF Suzhou Keen Therapeutics Co., Ltd. (CN) 2025-06-11 EP disclosed
WO-2023241620-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2023-12-21 WO disclosed